EGFR and cholangiocarcinoma: Alterations of epidermal growth factor receptor (ERBB) family have been reported in CCA, mostly in gallbladder cancer (19%) and in pCCA/dCCA (17%) [43], as compared to iCCA (4.8%) [58].